Kawecka-Jaszcz Kalina, Bednarek Agnieszka
I Klinika Kardiologii i Nadciśnienia Tetniczego, Instytutu Kardiologii, Uniwersytet Jagielloński, Collegium Medicum, Kraków.
Przegl Lek. 2012;69(2):82-6.
Cardiovascular disease and cancer are the two leading causes of death in the world, therefore a patient may have cancer, but also heart disease. Intensive cancer treatment, including chemotherapy and radiotherapy, improves the prognosis, reduces mortality and lengthens patients' lives but it is also associated with cardiotoxicity. This paper describes cardiovascular risk factors and methods for the estimation of individual risk before initiation of oncology treatment in subjects at high baseline risk of heart disease. We also describe the way of monitoring patients receiving potentially cardiotoxic treatment and the management of congestive heart failure, coronary artery disease and hypertension in these subjects.
心血管疾病和癌症是全球两大主要死因,因此患者可能患有癌症,也可能患有心脏病。包括化疗和放疗在内的强化癌症治疗可改善预后、降低死亡率并延长患者生命,但同时也与心脏毒性相关。本文描述了在心脏病基线风险较高的受试者开始肿瘤治疗前,心血管危险因素及个体风险评估方法。我们还描述了对接受潜在心脏毒性治疗的患者进行监测的方式,以及这些受试者充血性心力衰竭、冠状动脉疾病和高血压的管理方法。